HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Agnes Proszenyak Selected Research

Multiple Myeloma

10/2016The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Agnes Proszenyak Research Topics

Disease

2Neoplasms (Cancer)
11/2020 - 10/2016
2Leukemia
11/2020 - 10/2016
1Multiple Myeloma
10/2016
1Lymphoma (Lymphomas)
10/2016

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
11/2020 - 10/2016
1S63845IBA
10/2016

Therapy/Procedure

1Therapeutics
11/2020
1Drug Therapy (Chemotherapy)
11/2020